Clinical Trial Update: First-In Man (FIM) Study MR-Linac [NA]

View source ↗

Summary

The document reports a completed first-in-man study of the MR-Linac radiotherapy device for treating bone metastases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases

Snippet

Sponsor: Nucletron Operations BV | Conditions: Bone Metastases | NA | Status: COMPLETED